I guess if he can negotiate the sale of BBP as well as he negotiated his 'pay & rations' - we should be well rewarded in terms of the outcome.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%